Clinical Relevance of


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
20 08 2021
Historique:
received: 25 06 2021
revised: 17 08 2021
accepted: 18 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 8 2 2022
Statut: epublish

Résumé

We evaluated the association of

Identifiants

pubmed: 34440447
pii: genes12081271
doi: 10.3390/genes12081271
pmc: PMC8393853
pii:
doi:

Substances chimiques

VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Pharmacogenomics. 2007 Jan;8(1):49-66
pubmed: 17187509
J Pers Med. 2020 Dec 01;10(4):
pubmed: 33271790
Blood. 2009 Mar 26;113(13):2895-901
pubmed: 18988864
J Clin Pathol. 2011 Mar;64(3):226-31
pubmed: 21217153
Blood. 2020 Jan 9;135(2):82-83
pubmed: 31917838
Pathobiology. 2007;74(2):89-96
pubmed: 17587880
Br J Haematol. 2008 Jan;140(1):71-9
pubmed: 17983459
Expert Rev Mol Diagn. 2016;16(1):11-23
pubmed: 26636627
Nat Genet. 2009 Apr;41(4):446-9
pubmed: 19287382
Clin Cancer Res. 2015 Feb 15;21(4):687-92
pubmed: 25501578
Am J Hematol. 2018 Jan;93(1):100-106
pubmed: 29047144
Hematology. 2007 Dec;12(6):481-6
pubmed: 17852434
Eur J Haematol. 2005 Jan;74(1):35-9
pubmed: 15613104
Chest. 2011 Jul;140(1):16-18
pubmed: 21729890
Breast Cancer Res Treat. 2012 Jun;133(2):769-78
pubmed: 22315135
Leukemia. 2001 Jun;15(6):976-80
pubmed: 11417486
Nat Immunol. 2018 Jan;19(1):76-84
pubmed: 29180808
J Clin Lab Anal. 2019 Feb;33(2):e22686
pubmed: 30350881
Curr Cancer Drug Targets. 2011 Jan;11(1):72-84
pubmed: 21062247
Br J Haematol. 2009 Jul;146(2):150-7
pubmed: 19466975
Nat Commun. 2015 Apr 07;6:6691
pubmed: 25849990
Blood. 2001 Dec 1;98(12):3249-55
pubmed: 11719361
Memo. 2014;7:206-210
pubmed: 25544863
Medicina (Kaunas). 2017;53(1):34-39
pubmed: 28237691
Blood Adv. 2021 Apr 27;5(8):2184-2195
pubmed: 33890979
Nat Genet. 2009 Apr;41(4):450-4
pubmed: 19287385
Tumour Biol. 2016 Jan;37(1):1017-23
pubmed: 26264619
Eur Cytokine Netw. 2011 Sep;22(3):154-8
pubmed: 21982816
Am J Clin Pathol. 2007 Dec;128(6):966-73
pubmed: 18024322
Genet Test Mol Biomarkers. 2013 Jul;17(7):543-7
pubmed: 23586368
Oncotarget. 2017 Jul 25;8(30):50061-50070
pubmed: 28562357
Arch Pathol Lab Med. 2021 Feb 1;145(2):176-190
pubmed: 32886736
Leukemia. 2021 Feb;35(2):468-475
pubmed: 32536689
Arthritis Rheum. 2006 May;54(5):1588-94
pubmed: 16645995
Hematol Oncol. 2008 Dec;26(4):235-9
pubmed: 18504767
N Engl J Med. 2018 Oct 11;379(15):1416-1430
pubmed: 30304655
Nat Genet. 2009 Apr;41(4):455-9
pubmed: 19287384
J Natl Cancer Inst. 2013 Aug 21;105(16):1172-87
pubmed: 23852952
Blood. 2012 Oct 11;120(15):3112-7
pubmed: 22879541
Hum Pathol. 2007 Jul;38(7):1057-1064
pubmed: 17442379
Cytokine. 2018 Jun;106:29-34
pubmed: 29533820
Int J Gynecol Cancer. 2011 May;21(4):597-601
pubmed: 21543926
Leuk Res. 2020 Mar;90:106319
pubmed: 32081398
Mol Neurobiol. 2016 May;53(4):2610-8
pubmed: 26093379
Am J Hematol. 2019 Mar;94(3):299-305
pubmed: 30516848
Leuk Res. 2017 Sep;60:18-23
pubmed: 28622624

Auteurs

Laura Villani (L)

Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, 27100 Pavia, Italy.

Adriana Carolei (A)

Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, 27100 Pavia, Italy.

Vittorio Rosti (V)

Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, 27100 Pavia, Italy.

Margherita Massa (M)

Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, 27100 Pavia, Italy.

Rita Campanelli (R)

Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, 27100 Pavia, Italy.

Paolo Catarsi (P)

Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, 27100 Pavia, Italy.

Carlotta Abbà (C)

Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, 27100 Pavia, Italy.

Robert Peter Gale (RP)

Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London SW7 2BU, UK.

Giovanni Barosi (G)

Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, 27100 Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH